by Discovery | Oct 1, 2021 | Uncategorized
KeViRx is an early stage drug discovery company spun out of the UVA Department of Pharmacology by Elizabeth Sharlow and John Lazo and is located in Charlottesville. KeViRx was just awarded its second National Institutes of Health R43 Phase 1 Small Business Innovation...
by Discovery | Sep 1, 2021 | Uncategorized
Paul Carlier, a professor in the Department of Chemistry in the Virginia Tech College of Science and director of the Virginia Tech Center for Drug Discovery, and his colleagues received a $3.7 million grant from the National Institutes of Health to begin further...
by Discovery | Aug 19, 2021 | Uncategorized
For the first time, researchers have shown how cancer cells reprogram themselves to produce lactic acid and to tolerate the acidic environment that exists around tumors. The finding could lead to a whole new direction for treating cancer. Read More ->
by Discovery | Jun 16, 2021 | Uncategorized
The Santos lab will use the grant to take his prototype molecules and synthesize derivatives to enhance their effectiveness in treating NASH (nonalcoholic steatohepatitis), which is characterized by inflammation, fat accumulation, and scarring of the liver. Read more...
by Discovery | Jun 15, 2020 | Uncategorized
Dr. Elizabeth Sharlow has been promoted to Professor of Research in Pharmacology effective July 1, 2020. More about Dr....
